Hormones
Testosterone
Topical
Hormone health
Tesamorelin
Learn about growth-hormone signaling, specific indications, and safety considerations.
Medical guidance
Clinical review required
3
Prices are indicative market-aligned medication pricing, not a quote. A licensed pharmacy confirms the final price for the exact formulation after a state-licensed clinician reviews your case.
No published telehealth price was found for this compound.
Availability and treatment are not guaranteed.
vidameds
Compounded medications are not FDA-approved.
Understanding Tesamorelin
Know the treatment.
Ask better questions.
Tesamorelin is a growth-hormone-releasing hormone analog. FDA-approved formulations have a specific indication for reducing excess abdominal fat in adults with HIV-associated lipodystrophy, not general weight loss. The pictured formulation is not verified as an approved product.
How it works
It stimulates the pituitary to release growth hormone and can increase IGF-1. This does not establish suitability for wellness, performance, or routine weight management.
Safety & suitability
Important concerns include elevated IGF-1, glucose intolerance or diabetes, fluid retention, and hypersensitivity. Pregnancy, active malignancy, and certain pituitary conditions can rule out use. Appropriate medical evaluation and monitoring are essential.
Bring to your care conversation
- Does my diagnosis match the studied indication, and what monitoring would be needed?
- What is the exact formulation, and which approved alternatives should I consider?
- What side effects, interactions, and follow-up should we discuss before a decision?
Research, in perspective
What the evidence says.
A defined indication—not general weight loss.
A randomized trial in 412 adults with HIV and abdominal fat accumulation studied tesamorelin over 26 weeks. Its primary outcome was visceral fat measured by CT, not overall body-weight reduction.
Approved tesamorelin products have an indication for excess abdominal fat in HIV-associated lipodystrophy. This does not establish benefits for routine weight loss, healthy aging, or the unverified formulation pictured here.
Read the sourcesEvidence at a glance
What has been studied
Adults with HIV-associated abdominal fat accumulation using a specified trial formulation.
What remains unknown
General wellness benefits and equivalence of a compounded formulation.
What this means for you
Evidence must match the ingredient, formulation, and condition. A biological mechanism is not a guaranteed clinical result.
01
Growth-hormone-releasing hormone signaling
02
Growth hormone and IGF-1 response
03
Evidence applies to a specific HIV-associated condition
Sources & further reading
- 01Tesamorelin in HIV-associated abdominal fat accumulation (2007)
- 02FDA: EGRIFTA prescribing information (2019; historical formulation)
Research context is educational and does not confirm the safety, effectiveness, or availability of the pictured product.
The Vida Meds difference
Connected care.
Personal at every step.
A nationwide provider network. Direct pharmacy pricing. A team you can reach.
200+
Licensed providers
A nationwide network of licensed clinicians.
50 states
Nationwide care
Our provider network spans all 50 states.
Direct pharmacy
Pricing
Direct Pharmacy Pricing for your treatment.
Overnight
ColdChain Shipping
Temperature-controlled shipping for medications that require it.
24-hour
Customer support
Support for your questions, around the clock.
Direct access
Patient portal
Connect with your provider and dedicated care team.
Treatment eligibility, medication availability, and shipping arrangements depend on clinical review and the prescribed medication. Customer support is not emergency care; call 911 for a medical emergency.
Beyond the medication
Find your balance. On your terms.
Changes in energy, mood, and wellbeing deserve a thoughtful conversation. Explore hormone care informed by symptoms, appropriate testing, and your individual needs.
Explore hormone health
